These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4950605)

  • 1. Allergic reactions associated with viral vaccines.
    Isacson P; Stone A
    Prog Med Virol; 1971; 13():239-70. PubMed ID: 4950605
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hypersensitivity to myxoviruses and myxovirus vaccines in the guinea pig.
    Morris JA; Aulisio CG; Hoffman JC; Young BG
    Med Hypotheses; 1981 Mar; 7(3):353-61. PubMed ID: 6261102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic reactions to dental materials, drugs require an alert response from practitioner.
    Biron CR
    RDH; 1997 Feb; 17(2):42-4, 46-8. PubMed ID: 9442730
    [No Abstract]   [Full Text] [Related]  

  • 4. Live attenuated versus killed virus vaccines.
    Thomssen R
    Monogr Allergy; 1975; 9():155-76. PubMed ID: 1090805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM and IgG antibodies after immunization with organ-specific testicular antigen.
    Chutná J; Pokorná Z
    Folia Biol (Praha); 1967; 13(1):68-78. PubMed ID: 4167325
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allergic reactions in viral infections].
    Karpov SP
    Vopr Virusol; 1975; (1):3-9. PubMed ID: 164736
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine.
    Zent O; Hennig R
    Vaccine; 2004 Dec; 23(5):579-84. PubMed ID: 15542177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to local anaesthetics--update and proposal of evaluation algorithm.
    Thyssen JP; Menné T; Elberling J; Plaschke P; Johansen JD
    Contact Dermatitis; 2008 Aug; 59(2):69-78. PubMed ID: 18759873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimmunoallergic inflammation: new pathogenetic concepts and future perspectives of immediate and late allergic reactions. Part II.
    Nsouli TM; Nsouli SM; Bellanti JA
    Ann Allergy; 1988 Jun; 60(6):483-92. PubMed ID: 3289418
    [No Abstract]   [Full Text] [Related]  

  • 10. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
    Craighead JE
    J Infect Dis; 1975 Jun; 131(6):749-54. PubMed ID: 1169271
    [No Abstract]   [Full Text] [Related]  

  • 11. What you should know about new and current viral vaccines.
    Weibel RE
    Mod Med Asia; 1978 Jun; 14(6):28-34. PubMed ID: 207966
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue and medium antigens in vaccines--discussion.
    Feldman HA
    Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some problems of group hypersensitivities].
    Szyszymar B; Malaszyńska-Olkiewicz E; Szyszymar J
    Przegl Dermatol; 1970; 57(4):565-71. PubMed ID: 4394017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Allergy problems today].
    Poriadin GV; Poriadina GI; Golovko MG
    Med Sestra; 1988 Dec; 47(12):46-8. PubMed ID: 3237023
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of criteria for vaccine safety from the position of the immunopathology of infectious diseases].
    Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):3-7. PubMed ID: 193323
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivated myxovirus vaccines, atypical illness, and delayed hypersensitivity.
    Eller JJ
    J Pediatr; 1969 Apr; 74(4):664-6. PubMed ID: 4304439
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus.
    Openshaw PJ; Hussell T
    Dev Biol Stand; 1998; 92():179-85. PubMed ID: 9554273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine against respiratory syncytial virus.
    Lancet; 1969 Aug; 2(7615):311. PubMed ID: 4184224
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of delayed hypersensitivity to antibiotics].
    Mansur MC; Mansur JD; Azulay RD; Filardi C
    Med Cutan Ibero Lat Am; 1977; 5(2):135-50. PubMed ID: 345018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.